CUTTING-EDGE STRATEGIES IN THE ASYMMETRIC SYNTHESIS OF α-AMINOCYCLOPROPANE CARBOXYLIC ACIDS: ESSENTIAL SCAFFOLDS FOR DRUG DISCOVERY(Review)
№3 (English)

Як цитувати

Wzorek, A., Han, J., Ono, T., Klika, K., Baecker, D., Zhang, W., & Soloshonok, V. (2025). CUTTING-EDGE STRATEGIES IN THE ASYMMETRIC SYNTHESIS OF α-AMINOCYCLOPROPANE CARBOXYLIC ACIDS: ESSENTIAL SCAFFOLDS FOR DRUG DISCOVERY(Review). Український хімічний журнал, 91(10), 27-71. https://doi.org/10.33609/2708-129X.91.10.2025.27-71

Анотація

α-Aminocyclopropanecarboxylic acid (ACC) and its derivatives are widely distributed in the plant kingdom, fulfilling diverse roles ranging from regulation of plant life cycles to defensive mechanisms. The sterically constrained structure of ACC has proven invaluable in the design of numerous drugs, particularly hepatitis C virus (HCV) NS3/4A protease inhibitors. Indeed, ACC has been instrumental in the development of multiple generations of potent HCV treatments, with ongoing efforts focused on further improvements and refinements. The inherent steric constraints of these derivatives present a significant challenge for their synthesis, especially in enantiomerically pure form. This article provides a comprehensive overview of synthetic methodologies reported in the literature for the preparation of ACC and its derivatives. The synthetic strategies discussed herein are organized based on key transformations, including dialkylation of nucleophilic glycine equivalents, cyclopropanation of carbenoid glycine equivalents, and addition reactions to dehydroamino acids. Particular emphasis is placed on asymmetric approaches that enable the preparation of these tailor-made amino acids in enantiomerically pure form. Furthermore, aspects of Self-Disproportionation of Enantiomers (SDE) relevant to enantioselective catalysis are highlighted. By compiling these methodologies, we aim to provide a comprehensive resource and a source of inspiration for researchers in synthetic and medicinal chemistry, as well as drug discovery.

https://doi.org/10.33609/2708-129X.91.10.2025.27-71
№3 (English)

Посилання

Vickery H.B., Schmidt, C.L.A. The history of the discovery of the amino acids. Chem. Rev. 1931. 9(2): 169–318.

doi: 10.1021/cr60033a001.

McCoy R.H., Meyer C.E., Rose W.C. Feeding experiments with mixtures of highly purified amino acids. VIII. Isolation and identification of a new essential amino acid. J. Biol. Chem. 1935. 112: 283–302.

Sakami W., Harrington H. Amino acid meta¬bolism. Annu. Rev. Biochem. 1963. 32(1): 355–398.

doi: 10.1146/annurev.bi.32.070163.002035.

Soloshonok V.A., Izawa, K. Eds. Asymmetric Synthesis and Application of α-Amino Acids. ACS Symposium Series 1009. Washington, District of Columbia: American Chemical Society, 2009. DOI: 10.1021/bk-2009-1009.

Marasco D., Perretta G., Sabatella M., Ruvo M. Past and future perspectives of synthetic peptide libraries. Curr. Protein Pept. Sci. 2008. 9(5): 447–467.

doi: 10.2174/138920308785915209.

Han J., Konno H., Sato T. et al. Peptidomimetics and Peptide-Based Blockbuster Drugs. Curr. Org. Chem. 2021. 25(14): 1627–1658.

doi: 10.2174/1385272825666210610155047.

Liu J., Han J., Izawa K. et al. Cyclic tailor-made amino acids in the design of modern pharmaceuticals. Eur. J. Med. Chem. 2020. 208: 112736.

doi: 10.1016/j.ejmech.2020.112736.

Liu A., Han J., Nakano A. et al. New pharma¬ceuticals approved by FDA in 2020: Small-molecule drugs derived from amino acids and related compounds. Chirality. 2022. 34(1): 86–103.

doi: 10.1002/chir.23376.

Soloshonok V.A., Cai C., Hruby V.J., Meervelt L.V. Asymmetric synthesis of novel highly sterically constrained (2S,3S)-3-methyl-3-trifluoromethyl- and (2S,3S,4R)-3-trifluoromethyl-4-methylpyroglutamic acids. Tetrahedron. 1999. 55(41): 12045–12058.

doi: 10.1016/S0040-4020(99)00711-5.

Blaskovich M.A.T. Unusual amino acids in medicinal chemistry. J Med Chem. 2016. 59(24): 10807–10836.

doi: 10.1021/acs.jmedchem.6b00319.

Stevenazzi A., Marchini M., Sandrone G. et al. Amino acidic scaffolds bearing unnatural side chains: An old idea generates new and versatile tools for the life sciences. Bioorg. Med. Chem. Lett. 2014. 24(23): 5349–5356.

doi: 10.1016/j.bmcl.2014.10.016.

Han J., Konno H., Sato T. et al. Tailor-made amino acids in the design of small-molecule blockbuster drugs. Eur. J. Med. Chem. 2021. 220: 113448.

doi: 10.1016/j.ejmech.2021.113448.

Yin Z., Hu W., Zhang W. et al. Tailor-made amino acid-derived pharmaceuticals approved by the FDA in 2019. Amino Acids. 2020. 52(9): 1227–1261.

doi: 10.1007/s00726-020-02887-4.

Mei H., Han J., White S. et al. Tailor-made amino acids and fluorinated motifs as prominent traits in modern pharmaceuticals. Chem.—Eur. J. 2020. 26(50): 11349–11390.

doi: 10.1002/chem.202000617.

Wang Q., Han J., Sorochinsky A. et al. The Latest FDA-Approved Pharmaceuticals Containing Fragments of Tailor-Made Amino Acids and Fluorine. Pharmaceuticals. 2022. 15(8): 999.

doi.org/10.3390/ ph150809991847558.

Han J., Wzorek A. Dhawan G. et al. New drugs on the pharmaceutical market containing fluorine and residues of tailor-made amino acids. Ukr. Chem. J. 2024. 90(9): 31–56.

doi: 10.33609/2708-129X.90.9.2024.31-56.

Wang N., Mei H., Dhawan G. et al. New Approved Drugs Appearing in the Pharmaceutical Market in 2022, Featuring Fragments of Tailor-Made Amino Acids and Fluorine. Molecules. 2023. 28(9): 3651.

doi: 10.3390/molecules28093651.

Han J., Wzorek A., Dhawan G. et al. New drugs appearing on the market in 2023: molecules containing fluorine and fragments of tailor-made amino acids. Ukr. Bioorg. Acta. 2024. 19(1): 3–20.

doi: 10.15407/bioorganica2024.01.003.

Han J., Wzorek A., Dhawan G. et al. Chiral, fluorine-containing pharmaceuticals, Ukr. Chem. J. 2025. 91(2): 55–90.

doi.org/10.33609/2708-129X.91.2.2025.55-90.

Jianlin Han, Alicja Wzorek, Taizo Ono, Karel D. Klika, Vadim A. Soloshonok. Modern pharmaceutical drugs featuring aliphatic fluo¬rine-containing groups. Ukr. Chem. J. 2025. 91(6): 15–54.

Soloshonok V.A., Mikami K., Yamazaki T., Welch J.T., Honek J.F. Eds. Current fluoroorganic chemistry: new synthetic directions, technologies, materials, and biological applications. ACS Symposium Series #949. Oxford University Press. 2007.

doi: 10.1021/bk-2007-0949.

Vogt H., Bräse S. Recent approaches towards the asymmetric synthesis of α, α-disubstituted α-amino acids. Org. Biomolec. Chem. 2007. 5(3): 406–430.

doi.org/10.1039/B611091F.

Bera K., Namboothiri I.N. Asymmetric synthesis of quaternary α‐amino acids and their phosphonate analogues. Asian J. Org. Chem. 2014. 3(12):.1234-1260.

doi.org/10.1002/ajoc.201402178.

Metz A.E., Kozlowski M.C. Recent advances in asymmetric catalytic methods for the formation of acyclic α, α-disubstituted α-amino acids. J. Org. Chem. 2015. 80(1): 1-7.

doi.org/10.1021/jo502408z.

Wang Y., Song X., Wang J. et al. Recent approaches for asymmetric synthesis of α-amino acids via homologation of Ni (II) complexes. Amino Acids. 2017. 49: 1487–1520.

doi.org/10.1007/s00726-017-2458-6.

Zou Y., Han J., Saghyan A.S. et al. Asymmetric synthesis of tailor-made amino acids using chiral Ni (II) complexes of Schiff bases. An update of the recent literature. Molecules. 2020. 25(12): 2739.

doi.org/10.3390/molecules25122739.

Soloshonok V.A. Highly diastereoselective Michael addition reactions between nucleophilic glycine equivalents and β-substituted-α,β-unsaturated carboxylic acid derivatives; a gene¬ral approach to the stereochemically defined and sterically χ-constrained α-amino acids. Curr. Org. Chem. 2002. 6(4): 341–364.

doi: 10.2174/1385272024605014.

Soloshonok V.A., Sorochinsky A.E. Practical methods for the synthesis of symmetrically α,α-disubstituted α-amino acids. Synthesis. 2010. (14): 2319–2344.

doi: 10.1055/s-0029-1220013.

Metrano A.J., Miller S.J. Peptide-catalyzed conversion of racemic oxazol-5 (4 H)-ones into enantiomerically enriched α-amino acid derivatives. J. Org. Chem. 2014. 79(4): 1542–1554.

doi.org/10.1021/jo402828f.

So S.M., Moozeh K., Lough A.J., Chin J. Highly Stereoselective Recognition and Deracemi¬zation of Amino Acids by Supramolecular Self‐Assembly. Angew. Chemi. In. Ed. 2014. 53(3): 829–832.

doi.org/10.1002/anie.201307410.

Zhu H., Wang J., Lu Y. et al. Cu (II) Complexes with Proline-Derived Schiff Base Ligand: Chemical Resolution of N, C-Unprotected α-Amino Acids and Their Antibacterial Activity. J. Org. Chem. 2022. 87(19): 12900–12908.

doi.org/10.1021/acs.joc.2c01481.

Zhang F., Sun H., Song Z. et al. Stereoselective synthesis of arylglycine derivatives via palladium-catalyzed α-arylation of a chiral nickel (II) glycinate. J. Org. Chem. 2015. 80(9): 4459–4464.

doi.org/10.1021/acs.joc.5b00314.

Fanelli R., Jeanne-Julien L., René A. et al. Stereoselective synthesis of unsaturated α-amino acids. Amino Acids. 2015. 47: 1107-1115.

doi.org/10.1007/s00726-015-1934-0.

Schwieter K.E., Johnston J.N. Enantioselective synthesis of D-α-amino amides from alipha¬tic aldehydes. Chem. Scien. 2015. 6(4): 2590–2595.

DOI: 10.1039/C5SC00064E.

Yamada T., Okada T., Sakaguchi K. et al. Efficient asymmetric synthesis of novel 4-substituted and configurationally stable analogues of thalidomide. Org. Lett. 2006. 8(24): 5625–5628.

doi: 10.1021/ol0623668.

Soloshonok V.A., Ohkura H., Yasumoto M. Ope¬rationally convenient asymmetric synthesis of (S)- and (R)-3-amino-4,4,4-trifluorobutanoic acid: Part II. Enantioselective biomimetic transamination of 4,4,4-trifluoro-3-oxo-N-[(R)-1-phenylethyl)butanamide. J. Fluor. Chem. 2006. 127(7): 930–935.

doi: 10.1016/j.jfluchem.2006.04.004.

Takeda R., Kawamura A., Kawashima A. et al. Chemical dynamic kinetic resolution and S/R interconversion of unprotected α‐amino acids. Angew. Chem., Int. Ed. 2014. 53(45): 12214–12217.

doi.org/10.1002/anie.201407944.

Soloshonok V.A., Kirilenko A.G., Fokina N.A. et al. Biocatalytic resolution of β-fluoroalkyl-¬β-amino acids. Tetrahedron: Asymmetry. 1994. 5(6): 1119–1126.

doi.org/10.1016/0957-4166(94)80063-4.

Bravo P., Farina A., Kukhar V. P. et al. Stereoselective additions of α-lithiated alkyl-p-tolyl¬sulfoxides to N-PMP fluoroalkyl aldimines. An efficient approach to enantiomerically pure fluoro amino compounds. J. Org. Chem. 1997. 62(11): 3424–3425.

doi: 10.1021/jo970004v.

Turcheniuk K.V., Poliashko K.O., Kukhar V.P. et al. Efficient asymmetric synthesis of trifluoromethylated β-aminophosphonates and their incorporation into dipeptides. Chem. Commun. 2012. 48(94): 11519–11521.

doi: 10.1039/C2CC36702E

Nian Y., Wang J., Zhou S. et al. Recyclable li¬gands for the non‐enzymatic dynamic kinetic resolution of challenging α‐amino acids. Angew. Chem., Int. Ed. 2015. 54(44): 12918–12922.

doi.org/10.1002/anie.201507273.

Hruby V.J., Li G., Haskell‐Luevano C., Shende¬rovich M. Design of peptides, proteins, and peptidomimetics in chi space. Peptide Scien. 1997. 43(3): 219–266.

doi.org/10.1002/(SICI)1097-0282(1997)43:3 <219::AID-BIP3>3.0.CO;2-Y.

Hruby V.J., Balse P.M. Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads. Curr. Med. Chem. 2000. 7(9): 945–970.

doi.org/10.2174/0929867003374499.

Vagner J., Qu H., Hruby V.J. Peptidomimetics, a synthetic tool of drug discovery. Curr. Opin. Chem. Biol. 2008. 12(3): 292–296.

doi.org/10.1016/j.cbpa.2008.03.009.

Cai M., Cai C., Mayorov A.V. et al. Biological and conformational study of β‐substituted prolines in MT‐II template: steric effects leading to human MC5 receptor selectivity. J. Pep. Res. 2004. 63(2): 116–131.

doi.org/10.1111/j.1399-3011.2003.00105.x.

Qiu W., Gu X., Soloshonok V.A. et al. Stereo¬selective synthesis of conformationally constrained reverse turn dipeptide mimetics. Tetrahedron Lett. 2001. 42(2): 145–148.

doi: 10.1016/S0040-4039(00)01864-5.

Tang X, Soloshonok VA, Hruby VJ. Conveni¬ent, asymmetric synthesis of enantiomerically pure 2′, 6′-dimethyltyrosine (DMT) via alky¬lation of chiral equivalent of nucleophilic glycine. Tetrahedron: Asymmetry. 2000. 11(14): 2917–2925.

doi.org/10.1016/S0957-4166(00)00250-0.

Soloshonok V.A., Tang X., Hruby V.J. Large-scale asymmetric synthesis of novel sterically constrained 2′, 6′-dimethyl-and α, 2′, 6′-trimethyltyrosine and-phenylalanine derivatives via alkylation of chiral equivalents of nucleo¬philic glycine and alanine. Tetrahedron. 2001. 57(30): 6375–6382.

doi.org/10.1016/S0040-4020(01)00504-X.

Soloshonok V.A., Tang X., Hruby V.J., Meer¬velt L.V. Asymmetric synthesis of α, β-dialkyl-¬α-phenylalanines via direct alkylation of a chiral alanine derivative with racemic α-alkylbenzyl bromides. A case of high enantiomer differentiation at room temperature. Org. Lett. 2001. 3(3): 341–343.

doi.org/10.1021/ol000330o.

Soloshonok V.A., Cai C., Hruby V.J. Toward design of a practical methodology for stereocontrolled synthesis of χ-constrained pyroglutamic acids and related compounds. Virtually complete control of simple diastereoselectivity in the Michael addition reactions of glycine Ni (II) complexes with N-(enoyl) oxazolidinones. Tetrahedron Lett. 2000. 41(2): 135–139.

doi.org/10.1016/S0040-4039(99)02018-3.

Afonin S., Mikhailiuk P.K., Komarov I.V.,

Ulrich A.S. Evaluating the amino acid CF3‐bicyclopentylglycine as a new label for solid‐state 19F‐NMR structure analysis of membrane‐bound peptides. J. Pept. Scien. 2007. 13(9): 614–623. doi.org/10.1002/psc.854.

Cativiela C., Ordóñez M. Recent progress on the stereoselective synthesis of cyclic quaternary α-amino acids. Tetrahedron: Asymmetry. 2009. 20(1): 1–63.

doi.org/10.1016/j.tetasy.2009.01.002.

Brackmann F., de Meijere A. Natural occurrence, syntheses, and applications of cyclo¬pro¬pyl-group-containing α-amino acids. 1. 1-¬¬Ami¬no¬cyclopropanecarboxylic acid and other 2, 3-methanoamino acids. Chem. Rev. 2007. 107(11): 4493–4537.

doi.org/10.1021/cr078376j.

Burroughs L.F. 1-aminocyclopropane-l-carboxyIic acid: a new amino-acid in perry pears and cider apples. Nature. 1957. 179: 360–361.

DOI: 10.1038/179360a0.

Adams D.O., Yang S. Ethylene biosynthesis: identification of 1-aminocyclopropane-1-carboxylic acid as an intermediate in the conversion of methionine to ethylene. PNAS. 1979. 76(1): 170–174.

doi.org/10.1073/pnas.76.1.17.

Stammer C.H. Cyclopropane amino acids: 2,3-and 3,4-Methanoamino acids. Tetrahedron. 1990. 46(7): 2231–2254.

doi.org/10.1016/S0040-4020(01)82005-6.

Dorizon P., Su G., Ludvig G. et al. Stereoselective synthesis of highly functionalized cyclo¬propanes. Application to the asymmetric synthesis of (1S,2S)-2,3-methanoamino acids.

J. Org. Chem. 1999. 64(13): 4712–4724.

doi.org/10.1021/jo982528g.

Burgess K., Ho K.K., Moye-Sherman D. Asymmetric syntheses of 2,3-methanoamino acids. Synlett. 1994. (08): 575–583.

DOI: 10.1055/s-1994-22933.

Ichihara A., Shiraishi K., Sato H. et al. The structure of coronatine. J. Am. Chem. Soc. 1977. 99(2): 636–637. doi.org/10.1021/ja00444a067.

Mitchell R.E. Norcoronatine and N-coronafacoyl-L-valine, phytotoxic analogues of coro¬natine produced by a strain of Pseudomonas syringae pvglycinea. Phytochem. 1985. 24(7): 1485–1487.

doi.org/10.1016/S0031-9422(00)81049-3.

Hoffmann N.E., Yang S.F., Ichihara A., Sakamura S. Stereospecific conversion of 1-amino-cyclopropanecarboxylic acid to ethylene by plant tissues. Plant Physiol. 1982. 70:195–199.

doi.org/10.1104/pp.70.1.195.

Pirrung M.C., McGeehan G.M. Ethylene biosynthesis. 6. Synthesis and evaluation of me¬thyl-aminocyclopropanecarboxylic acid. J. Org. Chem. 1986. 51(11): 2103-2106.

doi.org/10.1021/jo00361a032.

Prelog V., Helmchen G. Basic principles of the CIP‐system and proposals for a revision. Angew. Chem., Int. Ed. 1982. 21(8): 567–583.

doi.org/10.1002/anie.198205671.

Klika K.D., Wzorek A., Soloshonok V.A. Internal chirality descriptors iR and iS and ire and isi. A proposed notation to extend the usefulness of the R/S system by retaining the sense of stereochemistry in cases of ligand ranking changes. Chirality. 2018. 30(9): 1054–1066.

doi: 10.1002/chir.22982.

Wang S., Wang Y., Wang J. et al. The second-¬generation of highly potent hepatitis C virus (HCV) NS3/4A protease inhibitors: Evolutionary design based on tailor-made amino acids, synthesis and major features of bio-activity. Curr. Pharmaceut. Design. 2017. 23(30): 4493–4554.

DOI: 10.2174/1381612823666170522122424.

Kakeya H., Zhang H.P., Kobinata K. et al. Cytotrienin A, a novel apoptosis inducer in human leukemia HL-60 cells. J. Antibiotics. 1997. 50(4): 370-372.

doi.org/10.7164/antibiotics.50.370.

Cheng Z., Lou L., Liu D. et al. Versiquinazolines A–K, fumiquinazoline-type alkaloids from the gorgonian-derived fungus Aspergillus versicolor LZD-14-1. J. Nat. Prod. 2016. 79(11): 2941–2952.

doi.org/10.1021/acs.jnatprod.6b00801.

Zhuang Y., Teng X., Wang Y. et al. New quinazolinone alkaloids within rare amino acid re¬sidue from coral-associated fungus, Aspergillus versicolor LCJ-5-4. Org. Lett. 2011. 13(5): 1130–1133.

doi.org/10.1021/ol103164n.

Cai S., Du L., Gerea A.L. et al. Spiro fused diterpene–indole alkaloids from a creek-bottom-derived Aspergillus terreus. Org. Lett. 2013. 15(16): 4186–4189.

doi.org/10.1021/ol401891z.

Bender C.L., Alarcón-Chaidez F., Gross D.C. Pseudomonas syringae phytotoxins: mode of action, regulation, and biosynthesis by peptide and polyketide synthetases. Microbiol. Molec. Biol. Rev. 1999. 63(2): 266–292.

doi.org/10.1128/mmbr.63.2.266-292.1999.

Li Y., Liu J., Díaz-Cruz G. et al. Virulence mechanisms of plant-pathogenic Streptomyces species: an updated review. Microbiol. 2019. 165(10): 1025–1040.

doi.org/10.1099/mic.0.000818.

Bignell D.R., Cheng Z., Bown L. The coronafacoyl phytotoxins: structure, biosynthesis, re¬gulation and biological activities. Antonie Van Leeuwenhoek. 2018. 111: 649–666.

doi.org/10.1007/s10482-017-1009-1.

Ronald P., Joe A. Molecular mimicry modulates plant host responses to pathogens. Ann. Bot. 2018. 121(1): 17–23.

doi.org/10.1093/aob/mcx125.

Fernando I.S., Nah J.W., Jeon Y.J. Potential anti-inflammatory natural products from marine algae. Environmen. Toxicol. Pharmacol. 2016. 48: 22–30.

doi.org/10.1016/j.etap.2016.09.023.

Sharma K.K., Sharma K., Rao K. et al. Unna¬tural amino acids: strategies, designs, and applications in medicinal chemistry and drug discovery. J. Med. Chem. 2024. 67(22): 19932–19965.

doi.org/10.1021/acs.jmedchem.4c00110.

Zhang Z., Sun Y., Li Y. et al. The potential of marine-derived piperazine alkaloids: Sources, structures and bioactivities. Eur. J. Med. Chem. 2024. 265: 116081.

doi.org/10.1016/j.ejmech.2023.116081.

He D., Wang M., Zhao S. et al. Pharmaceutical prospects of naturally occurring quinazolinone and its derivatives. Fitoterapia. 2017. 119: 136–149.

doi.org/10.1016/j.fitote.2017.05.001.

Zhang S.S., Meng Z.H., Zhao G.Z. et al. Aspergillus versicolor as a source of diversified me¬tabolic products with pharmacological activities. Stud. Nat. Prod. Chem. 2022. 74: 225–277.

doi.org/10.1016/B978-0-323-91099-6.00015-3.

Ciotti M., Angeletti S., Minieri M. et al.

CO¬VID-19 outbreak: an overview. Chemotherapy. 2020. 64(5–6): 215–223.

doi.org/10.1159/000507423.

Yuan Y., Jiao B., Qu L. et al. The development of COVID-19 treatment. Front. Immunol. 2023. 14: 1125246.

doi.org/10.3389/fimmu.2023.1125246.

Ohimain E.I., Silas-Olu D. The 2013–2016 Ebola virus disease outbreak in West Africa. Curr. Opin. Pharmacol. 2021. 60: 360–365.

doi.org/10.1016/j.coph.2021.08.002.

Gentile I., Buonomo A.R., Zappulo E., Borgia G. Discontinued drugs in 2012–2013: he¬pa¬titis C virus infection. Expert Opin. Investigat. Drugs. 2015. 24(2): 239–251.

doi.org/10.1517/13543784.2015.982274.

Njoroge F.G., Chen K.X., Shih N.Y., Piwinski J.J. Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection. Acc. Chem. Res. 2008. 41(1): 50–59.

doi.org/10.1021/ar700109k.

Revill P., Serradell N., Bolos J., Rosa E. Telaprevir. Drugs Future. 2007. 32(9): 788–798.

DOI: 10.1358/dof.2007.032.09.1138229.

Eley T., Garimella T., Li W., Bertz R.J. Asuna¬previr: a review of preclinical and clinical pharmacokinetics and drug–drug interactions. Clin. Pharmacokin. 2015. 54: 1205–1222.

doi.org/10.1007/s40262-015-0299-6.

Izquierdo L., Helle F., François C. et al. Simeprevir for the treatment of hepatitis C virus infection. Pharmacogenom. Personal. Med. 2014. 241–249.

doi.org/10.2147/PGPM.S52715.

Menon R.M., Polepally A.R., Khatri A. et al. Clinical pharmacokinetics of paritaprevir. Clin. Pharmacokin. 2017. ;56: 1125–1137.

doi.org/10.1007/s40262-017-0520-x.

Das D., Pandya M. Recent advancement of direct-acting antiviral agents (DAAs) in hepa¬titis C therapy. Mini Rev. Med. Chem. 2018. 18(7): 584-596.

doi.org/10.2174/138955751766617091311193.

Du Y., Semghouli A., Wang Q. et al. FDA‐approved drugs featuring macrocycles or medium‐sized rings. Archiv Pharmazie. 2025. 358(1): e2400890.

doi.org/10.1002/ardp.202400890.

Lee H.W., Jung K.S., Ahn S.H. Treatment of chronic hepatitis C using newly developed oral antiviral agents. Kor. J. Med. 2015. 88(6): 635-642.

doi.org/10.3904/kjm.2015.88.6.635.

Brennan B.J., Poirier A., Moreira S. et al. Cha¬racterization of the transmembrane transport and absolute bioavailability of the HCV protease inhibitor danoprevir. Clin. Pharmacokin. 2015. 54: 537–549.

doi.org/10.1007/s40262-014-0222-6.

Cotter T.G., Jensen D.M. Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy. Drug Design Develop. Ther. 2019. 29: 2565–2577.

doi.org/10.2147/DDDT.S172512.

Yang H., Yang C., Wang Y. et al. Preclinical characterization of the novel HCV NS3 protease inhibitor GS-9256. Antivir. Ther. 2017. 22(5): 413–420.

doi.org/10.3851/IMP3132.

Wzorek A., Klika K., Han J. et al. Enantio¬mer Purification Through Achiral Chromatography: Integrating Simulated Moving Bed and Self-Disproportionation of Enantiomers. Ukr. Chem. J. 2025. 91(3): 34–48.

doi.org/10.33609/2708-129X.91.3.2025.34-48.

Du Y., Bian Y., Baecker D. et al. Fluorine in the Pharmaceutical Industry: FDA‐Approved Fluo-rine‐Containing Drugs in 2024. Chem. Eur. J. 2025. 31(25): e202500662.

doi.org/10.1002/chem.202500662.

Wang Q., Bian Y., Dhawan G. et al. FDA approved fluorine-containing drugs in 2023. Chin. Chem. Lett. 2024. 35(11): 109780.

doi: 10.1016/j.cclet.2024.109780.

Bravo P., Guidetti M., Viani F. et al. Chiral sulfoxide controlled asymmetric additions to C N double bond. An efficient approach to stereochemically defined α-fluoroalkyl amino compounds. Tetrahedron. 1998. 54(42): 12789–12806.

doi: 10.1016/S0040-4020(98)00779-0.

Wang J., Sánchez-Roselló M., Aceña J.L. et al. Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001–2011). Chem. Rev. 2014. 114(4): 2432–2506.

doi.org/10.1021/cr4002879.

Zhou Y., Wang J., Gu Z. et al. Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. Chem. Rev. 2016. 116(2): 422–518.

doi: 10.1021/acs.chemrev.5b00392.

Han J., Kiss L., Mei H. et al. Chemical aspects of human and environmental overload with fluorine. Chem. Rev. 2021. 121(8): 4678–4742.

doi.org/10.1021/acs.chemrev.0c01263.

Röschenthaler G.V., Kukhar V.P., Kulik I.B. et al. Asymmetric synthesis of phosphonotrifluoroalanine and its derivatives using N-tert-butanesulfinyl imine derived from fluoral. Tetrahedron Lett. 2012. 53(5): 539–542.

doi:10.1016/j.tetlet.2011.11.096.

Soloshonok V.A., Belokon Y.N., Kuzmina N.A. et al. Asymmetric synthesis of phosphorus analogues of dicarboxylic α-amino acids. J. Chem. Soc. Perkin Transac. 1. 1992. (12): 1525–1529.

doi.org/10.1039/P19920001525.

Turcheniuk K.V., Kukhar V.P., Röschentha¬ler G.V. et al. Recent advances in the synthesis of fluorinated aminophosphonates and aminophosphonic acids. RSC Adv. 2013. 3(19): 6693–6716. DOI: 10.1039/c3ra22891f.

Walsh C., Pascal Jr R.A., Johnston M. et al. Mechanistic studies on the pyridoxal phosphate enzyme 1-aminocyclopropane-1-carboxylate deaminase from Pseudomonas sp. Biochem. 1981. 20(26): 7509–7519.

doi.org/10.1021/bi00529a028.

Beaulieu P.L., Gillard J., Bailey M.D. et al. Synthesis of (1R,2S)-1-Amino-2-vinylcyclopropanecarboxylic Acid Vinyl-ACCA Derivatives: Key Intermediates for the Preparation of Inhibitors of the Hepatitis C Virus NS3 Protease. J. Org. Chem. 2005. 70(15): 5869–5879.

doi.org/10.1021/jo050468q.

Park N.H., Teverovskiy G., Buchwald S.L. Development of an air-stable nickel precatalyst for the amination of aryl chlorides, sulfamates, mesylates, and triflates. Org. Lett. 2014. 16(1): 220–223.

doi.org/10.1021/ol403209k.

Boyall D., Frantz D.E., Carreira E.M. Efficient enantioselective additions of terminal alkynes and aldehydes under operationally convenient conditions. Org. Lett. 2002. 4(15): 2605–2606.

doi.org/10.1021/ol026282k.

Moore J.L., Taylor S.M., Soloshonok V.A. An efficient and operationally convenient ge¬neral synthesis of tertiary amines by direct alkylation of secondary amines with alkyl halides in the presence of Huenig’s base. Arkivoc. 2005. 6(iv): 287–292.

doi.org/10.3998/ark.5550190.0006.624.

Soloshonok V.A., Kirilenko A.G., Fokina N.A. et al. Chemo-enzymatic approach to the synthesis of each of the four isomers of α-alkyl-β-fluoroalkyl-substituted β-amino acids. Tetrahedron: Asymmetry. 1994. 5(7): 1225–1228.

doi.org/10.1016/0957-4166(94)80163-0.

Sorochinsky A.E., Ueki H., Aceña J.L. et al. Chemical deracemization and (S) to (R) interconversion of some fluorine-containing α-amino acids. J. Fluor. Chem. 2013. 152: 114–118.

doi.org/10.1016/j.jfluchem.2013.02.022.

Soloshonok V.A., Soloshonok I.V., Kukhar V.P., Svedas V.K. Biomimetic transamination of α-alkyl β-keto carboxylic esters. Chemoenzymatic approach to the stereochemically defined α-alkyl β-fluoroalkyl β-amino acids. J. Org. Chem. 1998. 63(6): 1878–1884.

doi.org/10.1021/jo971777m.

Belyk K.M., Xiang B., Bulger P.G. et al. Enantioselective synthesis of (1R,2S)-1-ami¬no-¬2-vinylcyclopropanecarboxylic acid ethyl ester (Vinyl-ACCA-OEt) by asymmetric phase-transfer catalyzed cyclopropanation of (E)-N-phenylmethyleneglycine ethyl ester. Org. Proc. Res. Develop. 2010. 14(3): 692–700.

doi.org/10.1021/op100070d.

Lou S., Cuniere N., Su B.N., Hobson L.A. Concise asymmetric synthesis of a (1R,2S)-1-amino-2-vinylcyclopropanecarboxylic acid-derived sulfonamide and ethyl ester. Org. Biomol. Chem. 2013. 11(39): 6796–6805.

doi.org/10.1039/C3OB41394B.

Nakamura T., Tateishi K. Tsukagoshi, S. et al. Self-Disproportionation of Enantiomers of Non-racemic Chiral Amine Derivatives Through Achiral Chromatography. Tetrahedron. 2012. 68: 4013–4017.

doi:10.1016/j.tet.2012.03.054.

Suzuki Y., Han J., Kitagawa O. et al. A comprehensive examination of the self-disproportionation of enantiomers (SDE) of chiral amides via achiral, laboratory-routine, gra¬vity-driven column chromatography. RSC Adv. 2015. 5: 2988–2993;

DOI: 10.1039/C4RA13928C.

Soloshonok V.A. Remarkable amplification of the self‐disproportionation of enantio¬mers on achiral‐phase chromatography co¬lumns. Angew. Chem. Int. Ed. 2006. 45(5): 766–769.

doi.org/10.1002/anie.200503373.

Hercouet A., Bessières B., Le Corre M. First asymmetric synthesis of (−)-(2S,3R)-metha¬noproline. Tetrahedron: Asymmetry. 1996. 7(5): 1267–1268.

doi.org/10.1016/0957-4166(96)00139-5.

Sorochinsky A.E., Ueki H., Aceña J.L. et al. Chemical approach for interconversion of (S)-and (R)-α-amino acids. Org. Biomol. Chem. 2013. 11(27): 4503–4507.

DOI:10.1039/C3OB40541A.

Takeda R., Abe H., Shibata N. et al. Asymmetric synthesis of α-deuterated α-amino acids. Org. Biomol. Chem. 2017. 15(33): 6978–6983.

doi.org/10.1039/C7OB01720K.

Joerres M., Aceña J.L., Soloshonok V.A., Bolm C. Asymmetric carbon–carbon bond formation under solventless conditions in ball mills. ChemCatChem. 2015. 7(8): 1265–1269.

doi.org/10.1002/cctc.201500102.

Jörres M., Chen X., Aceña J.L. et al. Asymmetric synthesis of α‐amino acids under operationally convenient conditions. Adv. Syn. Cat. 2014. 356(10): 2203–2208.

doi.org/10.1002/adsc.201400405.

Li T., Zhou S., Wang J. et al. Asymmetric synthesis of α-(1-oxoisoindolin-3-yl) glycine: Synthetic and mechanistic challenges. Chem. Commun. 2015. 51(9): 1624–1626.

DOI: 10.1039/C4CC05659K.

Soloshonok V.A., Kukhar V.P., Galushko S.V. et al. General method for the synthesis of enantiomerically pure β-hydroxy-α-amino acids, containing fluorine atoms in the side chains. Case of stereochemical distinction between methyl and trifluoromethyl groups. X-Ray crystal and molecular structure of the nickel (II) complex of (2S,3S)-2 (trifluoromethyl) threonine. J. Chem. Soc. Perkin Trans. 1. 1993. (24): 3143–3155.

doi.org/10.1039/P19930003143.

Soloshonok V.A,. Avilov D.V., Kukhar V.P. Highly diastereoselective asymmetric aldol reactions of chiral Ni (II)-complex of glycine with alkyl trifluoromethyl ketones. Tetrahedron: Asymmetry. 1996. 7(6): 1547–1550.

doi.org/10.1016/0957-4166(96)00177-2.

Zou Y., Yin Z., Mei H. et al. Aldol addition-cyclization reaction cascade on a platform of chiral Ni (II) complex of glycine schiff base. Ukr. Bioorgan. Acta. 2021. 16(1): 3-9.

doi.org/10.15407/bioorganica2021.01.003.

Yamada T., Sakaguchi K., Shinada T. et al. Efficient asymmetric synthesis of the functionalized pyroglutamate core unit common to oxazolomycin and neooxazolomycin using Michael reaction of nucleophilic glycine Schiff base with α, β-disubstituted acrylate. Tetrahedron: Asymmetry. 2008. 19(24): 2789–2795.

doi.org/10.1016/j.tetasy.2008.11.036.

Soloshonok V.A., Cai C., Hruby V.J. Asymmetric Michael addition reactions of chiral Ni (II)-complex of glycine with (N-trans-enoyl) oxazolidines: improved reactivity and stereochemical outcome. Tetrahedron: Asymmetry. 1999. 10(22): 4265–4269.

doi.org/10.1016/S0957-4166(99)00483-8.

Soloshonok V.A., Cai C., Hruby V.J. A unique case of face diastereoselectivity in the Michael addition reactions between Ni (II)-complexes of glycine and chiral 3-(E-enoyl)-1, 3-oxazolidin-2-ones. Tetrahedron Lett. 2000. 41(49): 9645–9649.

doi.org/10.1016/S0040-4039(00)01737-8.

Soloshonok V.A., Avilov D.V., Kukhar V.P. et al. An efficient asymmetric synthesis of (2S,3S)-3-trifluoromethylpyroglutamic acid. Tetrahedron Lett. 1997. 38(27): 4903–4904.

doi: 10.1016/S0040-4039(97)01054-X.

Kawamura A., Moriwaki H., Roeschentha¬ler G.V. et al. Synthesis of (2S,3S)-β-(trifluoromethyl)-α, β-diamino acid by Mannich addition of glycine Schiff base Ni (II) complexes to N-tert-butylsulfinyl-3,3,3-trifluoroacetaldimine. J. Fluor. Chem. 2015. 171: 67–72.

doi: 10.1016/j.jfluchem.2014.09.013.

Soloshonok V.A., Avilov D.V., Kukhar V.P. et al. Highly diastereoselective aza-aldol reactions of a chiral Ni (II) complex of glycine with imines. An efficient asymmetric approach to 3-perfluoroalkyl-2,3-diamino acids. Tetrahedron Lett. 1997. 38(26): 4671–4674.

doi.org/10.1016/S0040-4039(97)00963-5.

Sorochinsky A.E., Aceña J.L., Moriwaki H. et al. Asymmetric synthesis of α-amino acids via homologation of Ni(II) complexes of glycine Schiff bases. Part 2: Aldol, Mannich addition reactions, deracemization and (S) to (R) interconversion of α-amino acids. Amino Acids. 2013. 45(5): 1017–1033.

doi: 10.1007/s00726-013-1580-3.

Qiu W., Soloshonok V..A, Cai C. et al. Convenient, large-scale asymmetric synthesis of enantiomerically pure trans-cinnamylgly¬cine and -α-alanine. Tetrahedron. 2000. 56(17): 2577–2582.

doi.org/10.1016/S0040-4020(00)00176-9.

Sorochinsky A.E., Aceña J.L., H. Moriwaki H. et al. Asymmetric synthesis of α-amino acids via homologation of Ni(II) complexes of glycine Schiff bases; Part 1: alkyl halide alkylations. Amino Acids. 2013. 45(4): 691–718.

doi: 10.1007/s00726-013-1539-4.

Aceña J.L., Sorochinsky A.E., Moriwaki H. et al. Synthesis of fluorine-containing α-amino acids in enantiomerically pure form via homologation of Ni(II) complexes of glycine and alanine Schiff bases. J. Fluor. Chem. 2013. 155: 21–38.

doi: 10.1016/j.jfluchem.2013.06.004.

Wang J., Lin D., Zhou S. et al. Asymmetric synthesis of sterically and electronically demanding linear ω-trifluoromethyl containing amino acids via alkylation of chiral equivalents of nucleophilic glycine and alanine. J. Org. Chem. 2011. 76(2): 684–687.

doi.org/10.1021/jo102031b.

Ellis T.K., Hochla V.M., Soloshonok V.A. Efficient synthesis of 2-aminoindane-2-carbo¬xylic acid via dialkylation of nucleo¬philic glycine equivalent. J. Org. Chem. 2003. 68(12): 4973–4976.

doi.org/10.1021/jo030065v.

Ellis T.K., Martin C.H., Ueki H., Soloshonok V.A. Efficient, practical synthesis of symmetrically α, α-disubstituted α-amino acids. Tetrahedron Lett. 2003. 44(5): 1063–1066.

doi.org/10.1016/S0040-4039(02)02719-3.

Ellis T.K., Martin C.H., Tsai G.M. et al. Efficient synthesis of sterically constrained symmetrically α, α-disubstituted α-amino acids under operationally convenient conditions. J. Org. Chem. 2003. 68(16): 6208–6214.

doi.org/10.1021/jo030075w.

Wang J., Liu H., Aceña J.L. et al. Synthesis of bis-α,α′-amino acids through diastereoselective bis-alkylations of chiral Ni (ii)-comp¬lexes of glycine. Org. Biomolec. Chem. 2013. 11(27): 4508–4515.

DOI:10.1039/C3OB40594J.

Ueki H., Ellis T.K., Martin C.H., Soloshonok V.A. Efficient large‐scale synthesis of pico¬linic acid‐derived nickel (II) complexes of glycine. Eur. J. Org. Chem. 2003. 2003. (10): 1954–1957.

DOI: 10.1002/ejoc.200200688.

Ueki H., Ellis T.K., Martin C.H. et al. Improved synthesis of proline-derived Ni (II) complexes of glycine: versatile chiral equi¬valents of nucleophilic glycine for general asymmetric synthesis of α-amino acids. J. Org. Chem. 2003. 68(18): 7104–7107.

DOI: 10.1021/jo0301494.

Houck D., Aceña J.L., Soloshonok V.A. Alkylations of Chiral Nickel (II) Complexes of Glycine under Phase‐Transfer Conditions. Helv. Chim. Acta. 2012. 95(12): 2672–2679.

DOI: 10.1002/hlca.201200536.

Taylor S.M., Yamada T., Ueki H., Soloshonok V.A. Asymmetric synthesis of enantiomerically pure 4-aminoglutamic acids via methy¬lenedimerization of chiral glycine equivalents with dichloromethane under operationally convenient conditions. Tetrahedron Lett. 2004. 45(50): 9159–9162.

doi.org/10.1016/j.tetlet.2004.10.111.

Sato T., Izawa K., Aceña J.L. et al. Tailor‐made α‐amino acids in the pharmaceutical industry: synthetic approaches to (1R,2S)‐1‐amino‐2‐vinylcyclopropane‐1‐carboxylic acid (vinyl‐ACCA). Eur. J. Org. Chem. 2016. (16): 2757–2774.

doi.org/10.1002/ejoc.201600112.

Kawashima A., Xie C., Mei H. et al. Asymmetric synthesis of (1R,2S)-1-amino-2-vinylcyclopropanecarboxylic acid by sequential SN 2–SN 2′ dialkylation of (R)-N-(benzyl) proline-derived glycine Schiff base Ni (ii) complex. RSC Adv. 2015. 5(2): 1051–1058.

DOI: 10.1039/C4RA12658K.

Debache A., Collet S., Bauchat P. et al. Belokon’s Ni (II) complex as a chiral masked glycine for the diastereoselective synthesis of 2-substituted 1-aminocyclopropane carbo¬xy¬lic acids. Tetrahedron: Asymmetry. 2001. 12(5): 761–764.

doi.org/10.1016/S0957-4166(01)00106-9.

Soloshonok V.A., Boettiger T.U., Bolene S.B. Asymmetric synthesis of (2S,3S)-and (2R,3R)-α,β-dialkyl-α-amino acids via alkylation of chiral nickel (II) complexes of aliphatic α-amino acids with racemic α-alkyl¬benzyl bromides. Synthesis. 2008. (16): 2594–2602.

DOI: 10.1055/s-2008-1067172.

Ellis T.K., Ueki H., Soloshonok V.A. New generation of nucleophilic glycine equivalents. Tetrahedron Lett. 2005. 46(6): 941–944.

doi.org/10.1016/j.tetlet.2004.12.050.

Soloshonok V.A., Ueki H., Ellis T.K. New generation of modular nucleophilic glycine equivalents for the general synthesis of α-amino acids. Synlett. 2009. (5): 704–715.

DOI: 10.1055/s-0028-1087929.

Soloshonok V.A., Ueki H., Ellis T.K. et al. Application of modular nucleophilic glycine equivalents for truly practical asymmetric synthesis of β-substituted pyroglutamic acids. Tetrahedron Lett. 2005. 46(7): 1107–1110.

doi.org/10.1016/j.tetlet.2004.12.093.

Nian Y., Wang J., Moriwaki H. et al. Ana¬lysis of crystallographic structures of Ni (ii) complexes of α-amino acid Schiff bases: elucidation of the substituent effect on stereo¬che¬mical preferences. Dalton Trans. 2017. 46(13): 4191–4198.

doi.org/10.1039/C7DT00014F.

Ellis T.K., Ueki H., Yamada T. et al. Design, synthesis, and evaluation of a new generation of modular nucleophilic glycine equi¬valents for the efficient synthesis of sterically constrained α-amino acids. J. Org. Chem. 2006. 71(22): 8572–8578.

doi.org/10.1021/jo0616198.

Romoff T.T., Ignacio B.G., Mansour N. et al. Large-scale synthesis of the glycine Schiff base Ni (II) complex derived from (S)-and (R)-N-(2-benzoyl-4-chlorophenyl)-1-[(3, 4-dichlorophenyl) methyl]-2-pyrrolidine¬car¬boxamide. Org. Proc. Res. Develop. 2020. 24(2): 294–300.

doi.org/10.1021/acs.oprd.9b00399.

Nian Y., Wang J., Zhou S. et al. Purely chemi¬cal approach for preparation of D-α-amino acids via (S)-to-(R)-interconversion of unprotected tailor-made α-amino acids. J. Org. Chem. 2016. 81(9): 3501–3508.

DOI: 10.1021/acs.joc.5b02707

Mei H., Han J., Takeda R. et al. Practical method for preparation of (S)-2-Amino-5, 5,

-trifluoropentanoic acid via dynamic kinetic resolution. ACS Omega. 2019. 4(7): 11844–11851.

DOI: 10.1021/acsomega.9b01537.

Bergagnini M., Fukushi K., Han J. et al. NH-type of chiral Ni (II) complexes of glycine Schiff base: design, structural evaluation, reactivity and synthetic applications. Org. Biomolec. Chem. 2014. 12(8): 1278–1291.

DOI:10.1039/C3OB41959B.

Ellis T.K., Soloshonok V.A. Design and Synthesis of a New Generation of ‘NH’-Ni (II) Complexes of Glycine Schiff Bases and their Unprecedented CH vs. NH Chemoselectivity in Alkyl Halide Alkylations and Michael Addition Reactions. Synlett. 2006. (4): 533–538.

DOI: 10.1055/s-2006-926252.

Takeda R., Kawamura A., Kawashima A. et al. Second-order asymmetric transformation and its application for the practical synthesis of α-amino acids. Org. Biomol. Chem. 2018. 16(27): 4968–4972.

DOI: 10.1039/C8OB00963E.

Takahashi M., Moriwaki H., Miwa T. et al. Large Scale Synthesis of Chiral (3 Z, 5 Z)-2, 7-¬Dihydro-1 H-azepine-Derived Hamari Ligand for General Asymmetric Synthesis of Tailor-Made Amino Acids. Org. Proc. Res. Develop. 2019. 23(4): 619–628.

DOI: 10.1021/acs.oprd.8b00406.

Wang S., Zhou S., Wang J. et al. Chemical dynamic thermodynamic resolution and S/R interconversion of unprotected unnatural tailor-made α-amino acids. J. Org. Chem. 2015. 80(20): 9817–9830.

DOI: 10.1021/acs.joc.5b01292.

Han J., Romoff T.T., Moriwaki H. et al. Development of Hamari ligands for practical asymmetric synthesis of tailor-made amino acids. ACS Omega. 2019. 4(21): 18942–18947.

DOI: 10.1021/acsomega.9b02940.

Kawashima A., Shu S., Takeda R. et al. Advanced asymmetric synthesis of (1R,2S)-¬1-amino-2-vinylcyclopropanecarboxylic acid by alkylation/cyclization of newly designed axially chiral Ni (II) complex of glycine Schiff base. Amino Acids. 2016. 48: 973–986.

DOI: 10.1007/s00726-015-2138-3.

O’Donnell M.J., Bruder W.A., Eckrich T.M. et al. Simple syntheses of the amino acids: 1-aminocyclopropane-1-carboxylic acid, cyc¬lo¬leucine and 2,6-diaminopimelic acid. Synthesis. 1984. (2): 127–128.

DOI: 10.1055/s-1984-30749.

Allwein S.P., Secord E.A., Martins A. et al. Convenient synthesis and isolation of 1-aminocyclopropane-1-carboxylic acid (ACC) and N-protected ACC derivatives. Synlett. 2004. (14): 2489-2492. DOI: 10.1055/s-2004-834793.

Vergne F., Aitken D.J., Husson H.P. Synthesis of 1-amino-1-(aminomethyl) cyclopropane and its monobenzamides. J. Org. Chem. 1992. 57(22): 6071–6075.

doi.org/10.1021/jo00048a054.

Soloshonok V.A., Hayashi T. Gold (I)-catalyzed asymmetric aldol reactions of fluorinated benzaldehydes with an α-isocyanoacetamide. Tetrahedron: Asymmetry. 1994. 5(6): 1091–1094.

doi.org/10.1016/0957-4166(94)80059-6.

Soloshonok V.A., Hayashi T. Gold (I)-catalyzed asymmetric aldol reaction of methyl isocyanoacetate with fluorinated benzaldehydes. Tetrahedron Lett. 1994. 35(17): 2713–2716.

doi.org/10.1016/S0040-4039(00)77013-4.

Schöllkopf U., Hoppe D., Jentsch R. Higher amino acids by alkylation of α‐metalated isocyano‐acetic or‐propionic esters. Angew. Chem. Int. Ed. 1971. 10(5): 331–333.

doi.org/10.1002/anie.197103312.

Soloshonok V.A., Hayashi T., Ishikawa K., Nagashima N. Highly diastereoselective aldol reaction of fluoroalkyl aryl ketones with methyl isocyanoacetate catalyzed by silver (I)/triethylamine. Tetrahedron Lett. 1994. 35(7): 1055–1058.

doi.org/10.1016/S0040-4039(00)79964-3.

Soloshonok V.A., Kacharov A.D., Avilov D.V. et al. Transition Metal/Base-Catalyzed Aldol Reactions of Isocyanoacetic Acid Derivatives with Prochiral Ketones, a Straightforward Approach to Stereochemically Defined β, β-Disubstituted-β-hydroxy-α-amino Acids.

Scope and Limitations. J. Org. Chem. 1997. 62(11): 3470–3479.

doi.org/10.1021/jo9623402.

Schöllkopf U., Hupfeld B., Gull R. Simple Synthesis of 1‐Amino‐1‐cyclopropanecarboxylic Acids from tert‐Butyl Isocyanoa¬cetate and Epoxides; Synthesis of Alkyl 5,6‐Dihydro‐4H‐1,3‐oxazine‐4‐carboxylates. Angew. Chem. Int. Ed. 1986. 25(8): 754–755. doi.org/10.1002/anie.198607541.

Pirrung M., McGeehan G.M. Cyclopropyl‐Substituted Aminocyclopropane Carboxylic Acid (Cyclopropyl‐ACC)—an Investigation of the Mechanism of Ethylene Biosynthesis. Angew. Chem. Int. Ed. 1985. 24(12): 1044–1045.

doi.org/10.1002/anie.198510441.

Semeno V.V., Vasylchenko V.O., Vashchenko B.V. et al. Building the housane: diastereoselective synthesis and characterization of bicyclo [2.1. 0] pentane carboxylic acids. J. Org. Chem. 2019. 85(4): 2321–2337.

doi.org/10.1021/acs.joc.9b03044.

De Kimpe N., Sulmon P., Stevens C.. Synthesis of 1-amino-2, 2-dialkylcyclopropanecarboxylic acids from β-chloroaldimines. Tetrahedron. 1991. 47(26): 4723–4738.

doi.org/10.1016/S0040-4020(01)86477-2.

Easton C.J., Tan E.W., Ward C.M. Synthesis of cyclopropyl amino acid derivatives. Austral. J. Chem. 1992. 45(2): 395–402.

doi.org/10.1071/CH9920395.

Subramanian P.K., Kalvin D.M., Ramalin¬gam K., Woodard R.W. Synthesis of (1S,2R)- and (1S,2S)-1-amino [2-2H] cyclopropane-¬1-carboxylic acids: The total 1H NMR assignment of cyclo [ACC-. alpha.-methyl-Phe].

J. Org. Chem. 1989. 54(2): 270–276.

doi.org/10.1021/jo00263a004.

Lorthiois E., Marek I., Normant J.F. Amino zinc enolate carbocyclization reactions. New access to polysubstituted piperidine derivatives. J. Org. Chem. 1998. 63(3): 566–574

doi.org/10.1021/jo971449m.

DeMuynck B.M., Zhang L., Ralph E.K., Nagib D.A. Cyclopropanation of unactivated alkenes with non-stabilized iron carbenes. Chem. 2024. 10(3): 1015–1027.

DOI: 10.1016/j.chempr.2024.01.006.

Alford JS, Davies HM. Expanding the scope of donor/acceptor carbenes to N-phthalimido donor groups: diastereoselective synthesis of 1-cyclopropane α-amino acids. Org. Lett. 2012. 14(23): 6020–6023.

doi.org/10.1021/ol3029127.

Ballini R., Palmieri A., Fiorini D. Synthesis and use of nitrocyclopropane derivatives. Arkivoc. 2007(7): 172–194.

Charette A.B., Wurz R.P., Ollevier T. Synthesis of α‐Nitro‐α‐diazocarbonyl Derivatives and Their Applications in the Cyclopropanation of Alkenes and in O H Insertion Reactions. Helv. Chim. Acta. 2002. 85(12): 4468–4484.

doi.org/10.1002/hlca.200290023.

Moreau B., Alberico D., Lindsay V.N., Charette A.B. Catalytic asymmetric synthesis of nitrocyclopropane carboxylates. Tetrahedron. 2012. 68(17): 3487–3496.

doi.org/10.1016/j.tet.2011.05.113.

Vanier S.F., Larouche G., Wurz R.P., Charette A.B. Formal synthesis of belactosin A and hormaomycin via a diastereoselective intramolecular cyclopropanation of an α-nitro diazoester. Org. Lett. 2010. 12(4): 672–675.

doi.org/10.1021/ol9026528.

Green S.P., Wheelhouse K.M., Payne A.D. et al. Thermal Stability and Explosive Hazard Assessment of Diazo Compounds and Diazo Transfer Reagents. Org. Proc. Res. Dev. 2020. 24(1:, 67−84.

DOI: 10.1055/s-0040-1719295.

Zhu S., Perman J.A., Zhang X.P. Acceptor/acceptor‐substituted diazo reagents for carbene transfers: cobalt‐catalyzed asymmetric Z‐cyclopropanation of alkenes with α‐nitrodiazoacetates. Angew. Chem. Int. Ed. 2008. 47(44): 8460–8463.

doi.org/10.1002/anie.200803857.

Doyle M.P. Exceptional selectivity in cyclopropanation reactions catalyzed by chiral cobalt (II) porphyrins. Angew. Chem. Int. Ed. 2009. 48(5): 850.

doi: 10.1002/anie.200804940.

Xu X., Lu H., Ruppel J.V et al. Highly asymmetric intramolecular cyclopropanation of acceptor-substituted diazoacetates by Co (II)-based metalloradical catalysis: iterative approach for development of new-gene¬ration catalysts. J. Am. Chem. Soc. 2011. 133(39): 15292–15295.

doi.org/10.1021/ja2062506.

Han J., Wzorek A., Kwiatkowska M. et al. The self-disproportionation of enantiomers (SDE) of amino acids and their derivatives. Amino Acids. 2019. 51(6): 865–889.

DOI: 10.1007/s00726-019-02729-y.

Wzorek A., Klika K.D., Drabowicz J. et al. The self-disproportionation of the enantio¬mers (SDE) of methyl n-pentyl sulfoxide via achiral, gravity-driven column chromato¬graphy: a case study. Org Biomolec Chem. 2014. 12(26): 4738–4746.

DOI: 10.1039/c4ob00831f.

Wzorek A., Sato A., Drabowicz J. et al. Remarkable magnitude of the self-disproportionation of enantiomers (SDE) via achiral chromatography: application to the practical-scale enantiopurification of β-amino acid esters. Amino Acids. 2016. 48: 605–613.

DOI: 10.1007/s00726-015-2152-5.

Yasumoto M., Ueki H., Ono T. et al. Self-Disproportionation of Enantiomers via Sublimation: Isopropyl 3,3,3-(Trifluoro)-Lactate. J. Fluor. Chem. 2010. 131: 535–539.

doi.org/10.1016/j.jfluchem.2009.11.026.

Yasumoto M., Ueki H., Soloshonok V.A. Self-Disproportionation of Enantiomers of Trifluoro Lactic Acid Amides via Sublimation. J. Fluor. Chem. 2010. 131: 266–269.

doi.org/10.1016/j.jfluchem.2009.10.002.

Albrecht M., Soloshonok V.A., Schrader L. et al. Chirality-dependent sublimation of α-(trifluoromethyl)-lactic acid: Relative vapor pressures of racemic, eutectic, and enantiomerically pure forms, and vibrational spectroscopy of isolated (S,S) and (S,R) dimers. J. Fluor. Chem. 2010. 131(4): 495–504.

doi.org/10.1016/j.jfluchem.2009.11.015.

Feng L.W., Wang P., Wang L., Tang Y. Copper (I)/SaBOX catalyzed highly diastereo-and enantio-selective cyclopropanation of cis-1,2-disubstituted olefins with α-nitrodiazoacetates. Scien. Bull. 2015. 60: 210–215.

doi.org/10.1007/s11434-014-0708-5.

Li J., Liao S.H., Xiong H. et al. Highly Diastereo ‐and Enantioselective Cyclopropanation of 1,2‐Disubstituted Alkenes. Angew. Chem. Int. Ed. 2012. 51(35): 8838–8841.

DOI: 10.1002/anie.201203218.

Yasumoto M., Ueki H., Soloshonok V.A. Self-disproportionation of enantiomers of α-trifluoromethyl lactic acid amides via sublimation. J. Fluor. Chem. 2010. 131(4): 540–544.

doi.org/10.1016/j.jfluchem.2009.11.010.

Sorochinsky A.E., Soloshonok V.A. Self-disproportionation of enantiomers of enantiomerically enriched compounds. Differentiation of enantiomers II. 2013: 301–339.

doi.org/10.1007/128_2013_434.

Wzorek A., Sato A., Drabowicz J. et al. Enantiomeric Enrichments via the Self‐Disproportionation of Enantiomers (SDE) by Achiral, Gravity‐Driven Column Chromatography: a Case Study Using N‐(1‐Phenylethyl) acetamide for Optimizing the Enantiomerically Pure Yield and Magnitude of the SDE. Helv. Chim. Acta. 2015. 98(8): 1147–1159.

DOI: 10.1002/hlca.201500041.

Lodhi R., Prakash M., Samanta S. Diastereo¬selective desymmetrization reactions of prochiral para-quinamines with cyclopro¬penes generated in situ: access to fused hydroindol-5-one scaffolds. Org. Biomol. Chem. 2021. 19(33): 7129−7133.

doi.org/10.1039/D1OB01322J.

Müller, P. Asymmetric Transfer of Carbenes with Phenyliodonium Ylides. Acc. Chem. Res. 2004. 37(4): 243−251.

doi.org/10.1021/ar0202619.

Wurz R.P., Charette A.B. Hypervalent Iodi¬ne(III) Reagents as Safe Alternatives to α-¬Nitro-α-Diazocarbonyls. Org. Lett. 2003. 5(13): 2327−2329.

doi.org/10.1021/ol034672g.

Wurz R.P., Charette A.B. An expedient and practical method for the synthesis of a diverse series of cyclopropane α-amino acids

and amines. J. Org. Chem. 2004. 69(4): 1262−1269.

doi.org/10.1021/jo035596y.

Wurz R.P., Charette A.B. Doubly Activated Cyclopropanes as Synthetic Precursors for the Preparation of 4-Nitro- and 4-Cyano-Dihydropyrroles and Pyrroles. Org. Lett. 2005. 7(12): 2313−2316.

doi.org/10.1021/ol050442l.

Moreau B., Charette A.B. Expedient synthesis of cyclopropane α-amino acids by the catalytic asymmetric cyclopropanation of alkenes using iodonium ylides derived from methyl nitroacetate. J. Am. Chem. Soc. 2005. 127(51): 18014–1815.

doi.org/10.1021/ja056192l.

Moreau B., Alberico D., Lindsay V.N., Charette A.B. Catalytic asymmetric synthesis of nitrocyclopropane carboxylates. Tetra¬hedron. 2012. 68(17): 3487–3496.

doi.org/10.1016/j.tet.2011.05.113.

Charette A.B., Wurz R. Progress towards asymmetric intermolecular and intramole¬cular cyclopropanations using α-nitro-α-diazo carbonyl substrates. J. Mol. Cat. A Chem. 2003. 196(1-2): 83–91.

doi.org/10.1016/S1381-1169(02)00636-2.

Han J., Wzorek A., Soloshonok V.A., Klika K.D. The self‐disproportionation of enantiomers (SDE): The effect of scaling down, potential problems versus prospective applications, possible new occurrences, and unrealized opportunities?. Electrophoresis. 2019. 40(15): 1869–1880.

DOI: 10.1002/elps.201800414.

Wzorek A., Sato A., Drabowicz J., Soloshonok V.A. Self‐disproportionation of Enantiomers (SDE) of Chiral Nonracemic Amides via Achiral Chromatography. Isr. J. Chem. 2016. 56(11-12): 977–989.

DOI: 10.1002/ijch.201600077.

Wzorek A., Sato A., Drabowicz J., Soloshonok V.A. Self-disproportionation of enan¬tiomers via achiral gravity-driven column chromatography: A case study of N-acyl-¬α-phenylethylamines. J. Chrom. A. 2016. 1467: 270–278.

DOI: 10.1016/j.chroma.2016.05.044.

Terada S., Hirai M., Honzawa A. et al. Possible Case of Halogen Bond‐Driven Self‐Disproportionation of Enantiomers (SDE) via Achiral Chromatography. Chem. Eur. J. 2017. 23(58): 14631–14638.

DOI: 10.1002/chem.201703308.

Tateishi K., Tsukagoshi S., Nakamura T. et al. Chiral initiator-induces self-disproportionation of enantiomers via achiral chromatography: application to enantiomer separation of racemate. Tetrahedron Lett. 2013. 54(38): 5220–5223.

DOI: 10.1016/j.tetlet.2013.07.061.

Hosaka T., Imai T., Wzorek A. et al. The self-¬disproportionation of enantiomers (SDE) of α-amino acid derivatives: facets of steric and electronic properties. Amino Acids. 2019. 51: 283–294.

doi.org/10.1007/s00726-018-2664-x.

Afonso A., Hon F., Weinstein J. et al. A new synthesis of penems, the oxalimide cyclization reaction. J. Am. Chem. Soc. 1982. 104(22): 6138–6139.

doi.org/10.1021/ja00386a060.

Korda A., Winiarski J. Synthesis of (3,4) β-Methylenecepham and (3,4) β-Methy¬lene-carbacepham via intramolecular carbene addition to double bond. Bioorg. Med. Chem. 2003. 11(9): 1957–1967.

doi.org/10.1016/S0968-0896(03)00084-1.

Merino I., Hegedus L.S. Group 6 Pyrrolocarbene Complexes as Alkoxycarbene Comp¬lex Analogs. Organometallics. 1995. 14(5): 2522–2531.

doi.org/10.1021/om00005a058.

Barluenga J., Aznar F., Gutiérrez I. et al. First intermolecular cyclopropanation of Fischer dialkylaminocarbene complexes. Synthesis of 1-aminocyclopropanecarboxylic acid derivatives. Org. Lett. 2002. 4(24): 4273–4276.

doi.org/10.1021/ol026896p.

Alcaraz C., Fernández M.D., de Frutos M.P. et al. Asymmetric syntheses of 1-amino-¬2-phenyl (alkyl) cyclopropanecarboxylic acids by diastereoselective cyclopropanation of highly functionalized monochiral olefines. Tetrahedron. 1994. 50(43): 12443–12456.

doi.org/10.1016/S0040-4020(01)89550-8.

Gracia-Vitoria J., Osante I., Cativiela C. et al. Self-regeneration of chirality with L-cysteine through 1,3-dipolar cycloadditions between diazoalkanes and enantiomerically pure thia¬zolines: experimental and computational studies. J. Org. Chem. 2018. 83(7): 3960–3972.

doi.org/10.1021/acs.joc.8b00312.

Switzer F.L., Van Halbeek H., Holt E.M. et al. Synthesis of (±)-2,3-methanoproline: A novel inhibitor of ethylene biosynthesis. Tetrahedron. 1989. 45(19): 6091-6100.

doi.org/10.1016/S0040-4020(01)85122-X.

Donati D., Garzon-Aburbeh A., Natalini B. et al. Conformationally constrained trypto¬phan analogs. Synthesis of (±)-(Z)-and (±)-(E)-2-amino-2, 3-methano-3-(indol-3-yl)-propanoic acids. Tetrahedron. 1996. 52(29): 9901–9908.

doi.org/10.1016/0040-4020(96)00522-4.

Zou Y., Takeda R., Han J. et al. Asymmetric Synthesis of N‐Fmoc‐(S)‐7‐aza‐tryptophan via Alkylation of Chiral Nucleophilic Glycine Equivalent. Eur. J. Org. Chem. 2021. (21): 2962–2965.

DOI: 10.1002/ejoc.202100485.

Han J., Lyutenko N.V., Sorochinsky A.E. et al. Tailor‐Made Amino Acids in Pharmaceutical Industry: Synthetic Approaches to Aza‐Tryptophan Derivatives. Chem. Eur. J. 2021. 27: 17510–17528.

doi.org/10.1002/chem.202102485

Monnie C.M., Hernández I., Meléndez‐Pacheco R. et al. Synthesis of 4,6‐Difluoro‐Tryptophan as a Probe for Protein 19F NMR. Adv. Syn. Cat. 2024. 366(16): 3417–3422.

doi.org/10.1002/adsc.202400031.

Zhu C.L., Yang L.J., Li S. et al. Brine-stabilized 2,2,2-trifluorodiazoethane and its application in the synthesis of CF3–substituted cyclopropane α-amino acids. Org. Lett. 2015. 17(14): 3442–3445.

doi.org/10.1021/acs.orglett.5b01450.

Mikami K., Fustero S., Sánchez-Roselló M. et al. Synthesis of fluorinated β-amino acids. Synthesis. 2011. (19): 3045–3079.

doi: 10.1055/s-0030-1260173.

Suzuki M., Gooch E.E., Stammer C.H. A new synthesis of racemic coronamic acid and other cyclopropyl amino acids. Tetrahedron Lett. 1983. 24(36): 3839–3840.

doi.org/10.1016/S0040-4039(00)94289-8.

De Kimpe N., Sulmon P., Schamp N. Synthesis of 2,2-dimethyl-1-aminocyclopropa¬ne¬carboxylic acid from β-chloroimines. Tetrahedron Lett. 1989. 30(37): 5029–5032.

doi.org/10.1016/S0040-4039(01)80573-6.

Minami T., Tokumasu S., Mimasu R., Hirao I. Cycloaddition of diazomethane to butadienylphosphonates. A new approach to functionalized pentadienylphosphonates and pyrazoles. Chem. Lett. 1985. 14(8): 1099–1102.

doi.org/10.1246/cl.1985.1099.

Tokairin Y., Konno H., Noireau A. et al. Asymmetric synthesis of the two enantio¬mers of β-phosphorus-containing α-amino acids via hydrophosphinylation and hydrophosphonylation of chiral Ni (II)-complexes. Org. Chem. Front. 2021. 8(10): 2190–2195.

doi.org/10.1039/D1QO00159K.

Röschenthaler G.V., Kukhar V.P., Kulik I.B. et al. Convenient synthesis of fluoroalkyl α- and β-aminophosphonates. J. Fluor. Chem. 2011. 132(10): 834–837.

doi.org/10.1016/j.jfluchem.2011.05.005.

Xie C., Zhang L., Mei H. et al. New Chiral Reagent for Installation of Pharmacophoric (S)‐or (R)‐2‐(Alkoxyphosphono)‐1‐amino‐¬2,2‐¬difluoroethyl Groups. Chem. Eur. J. 2016. 22(21): 7036–7040.

DOI: 10.1002/chem.201600758.

Wzorek A., Han J., Lyutenko N.V. et al. Enzymatic approaches for preparation of α-aminophosphonic acids and fluorine-containing β-amino acids. Ukr. Bioorg. Acta. 2024. 19(1): 21–32.

doi.org/10.15407/bioorganica2024.01.021.

Adams L.A., Aggarwal V.K., Bonnert R.V. et al. Diastereoselective synthesis of cyclopropane amino acids using diazo compounds generated in situ. J. Org. Chem. 2003. 68(24): 9433-9440.

doi.org/10.1021/jo035060c.

Houck D., Aceña J.L., Soloshonok V.A. Alkylations of Chiral Nickel (II) Complexes of Glycine under Phase‐Transfer Conditions. Helv. Chim. Acta. 2012. 95(12): 2672–2679.

DOI: 10.1002/hlca.201200536.

Zhu C., Li J., Chen P. et al. Transition-me¬tal-free cyclopropanation of 2-aminoacrylates with N-tosylhydrazones: a general route to cyclopropane α-amino acid with contiguous quaternary carbon centers. Org. Lett. 2016. 18(6): 1470–1473.

doi.org/10.1021/acs.orglett.6b00416.

Zhang W., Sha W., Pajkert R. et al. β‐Amino‐γ,γ‐difluoro‐ω‐phosphonoglutamic Acid Derivatives: An Unexplored, Multifaceted Structural Type of Tailor‐Made α‐Amino Acids. Eur. J. Org. Chem. 2017. 3451–3456;

DOI: 10.1002/ejoc.201700570.

Kukhar V.P., Soloshonok V.A., Solodenko V.A. Asymmetric Synthesis of Phosphorus Analogs of Amino Acids, Phosph., Sulf., Silic. Relat. Elem. 1994. 92: 239–264.

DOI: 10.1080/10426509408021478.

Sorochinsky A.E., Soloshonok V.A. Asymmetric synthesis of fluorine-containing amines, amino alcohols, α-and β-amino acids mediated by chiral sulfinyl group. J. Fluor. Chem. 2010. 131(2): 127–139.

doi.org/10.1016/j.jfluchem.2009.09.015.

Lee W.C., Wang D.S., Zhang C. et al. Asymmetric radical cyclopropanation of dehydroaminocarboxylates: Stereoselective synthesis of cyclopropyl α-amino acids. Chem. 2021. 7(6): 1588–1601.

DOI: 10.1016/j.chempr.2021.03.002.

Wzorek A., Kamizela A., Sato A., Soloshonok V.A. Self-Disproportionation of Enantio¬mers (SDE) via achiral gravity-driven column chromatography of N-fluoroacyl-1-phenylethylamines. J. Fluor. Chem. 2017. 196: 37–43.

DOI: 10.1016/j.jfluchem.2016.07.016.

Goto M., Tateishi K., Ebine K. et al. Chiral additive induced self-disproportionation of enantiomers under MPLC conditions: preparation of enantiomerically pure samp¬les of 1-(aryl) ethylamines from racemates. Tetrahedron: Asymmetry. 2016. 27(7-8): 317–321.

DOI: 10.1016/j.tetasy.2016.03.004.

Kwiatkowska M., Marcinkowska M., Wzo¬rek A. et al. The self-disproportionation of enantiomers (SDE) via column chromatography of β-amino-α,α-difluorophospho¬nic acid derivatives. Amino Acids. 2019. 51: 1377–1385.

DOI: 10.1007/s00726-019-02774-7.

Allouche E.M., Charette A.B. Non-stabilized diazoalkane synthesis via the oxidation of free hydrazones by iodosylbenzene and application in in situ MIRC cyclopropanation. Chem. Scien. 2019. 10(13): 3802–3806.

DOI: 10.1039/C8SC05558K.

Takai K., Toshikawa S., Inoue A., Kokumai R. Stereoselective Iodocyclopropanation of Terminal Alkenes with Iodoform, Chromium (II) Chloride, and N,N,N‘,N‘-Tetraethylethylenediamine. J. Am. Chem. Soc. 2003. 125(43): 12990-12991.

doi.org/10.1021/ja0373061.

Concellón J.M., Rodríguez-Solla H., Méjica C., Blanco E.G. Stereospecific cyclopropanation of highly substituted C− C double bonds promoted by CrCl2. Stereoselective synthesis of cyclopropanecarboxamides and cyclopropyl ketones. Org. Lett. 2007. 9(16): 2981–2984.

doi.org/10.1021/ol070896d.

Liu H.L., Wang X., Gao K., Wang Z. Catalytic Diastereo‐and Enantioselective Cyclopropanation of gem‐Dihaloalkanes and Terminal Olefins. Angew. Chem. Int. Ed. 2023. 62(28): e202305987.

doi.org/10.1002/anie.202305987.

Soloshonok V.A., Klika K.D. Terminology Related to the Phenomenon ‘Self-Disproportionation of Enantiomers’ (SDE). Helv. Chem Acta. 2014. 97: 1583–1589.

DOI: 10.1002/hlca.201400122.

Soloshonok V.A., Wzorek A., Klika K.D. A question of policy: should tests for the self-disproportionation of enantiomers (SDE) be mandatory for reports involving scalemates? Tetrahedron: Asymmetry. 2017. 28: 1430–1434.

DOI: 10.1016/j.tetasy.2017.08.020.

Sorochinsky A.E., Katagiri T., Ono T. et al. Optical purifications via Self-Disproportio¬nation of Enantiomers by achiral chromato¬graphy; Case study of a series of α-CF3-containing secondary alcohols. Chirality. 2013. 25: 365–368.

DOI: 10.1002/chir.22180.

Zhou R., Deng X., Zheng J. et al. Stereoselective Synthesis of 1‐Aminocyclopropanecarboxylic Acid Derivatives via Ylide Cyclopropanation of Dehydroamino Acid Derivatives. Chin. J. Chem. 2011. 29(5): 995–1000.

doi.org/10.1002/cjoc.201190202.

Papageorgiou C.D., Cubillo de Dios M.A., Ley S.V., Gaunt M.J. Enantioselective organocatalytic cyclopropanation via ammonium ylides. Angew. Chem. Int. Ed. 2004. 43(35): 4641–4644.

DOI: 10.1002/anie.200460234.

Li J.P., Zhao G.F., Wang H.X. et al. Highly enantioselective synthesis of chiral cyclopropyl nucleosides via catalytic asymmetric intermolecular cyclopropanation. Org Lett. 2017. 19(24): 6494–6497.

doi.org/10.1021/acs.orglett.7b03110.

Han J., Kitagawa O., Wzorek A. et al. The self-disproportionation of enantiomers (SDE): a menace or an opportunity? Chem. Scien. 2018. 9(7): 1718–1739.

DOI: 10.1039/C7SC05138G.

Ivashkin P., Couve-Bonnaire S., Jubault P., Pannecoucke X. Asymmetric Synthesis of Cyclopropanes with a Monofluorinated Quaternary Stereocenter. Org Lett. 2012. 14(19): 5130–5133.

doi.org/10.1021/ol3024264.

Sorochinsky A., Voloshin N., Markovsky A. et al. Convenient asymmetric synthesis of β-substituted α,α-difluoro-β-amino acids via Reformatsky reaction between Davis’ N-Sulfinylimines and ethyl bromodifluoroacetate. J. Org. Chem. 2003. 68(19): 7448–7454.

doi.org/10.1021/jo030082k.

Soloshonok V.A., Ueki H., Tiwari R. et al. Virtually complete control of simple and face diastereoselectivity in the Michael addition reactions between achiral equivalents of a nucleophilic glycine and (S)-or (R)-3-(E-enoyl)-4-phenyl-1, 3-oxazolidin-2-ones: practical method for preparation of β-substituted pyroglutamic acids and prolines. J. Org. Chem. 2004. 69(15): 4984–4990.

doi.org/10.1021/jo0495438.

Soloshonok V.A., Cai C., Hruby V.J. (S)-or (R)-3-(E-Enoyl)-4-phenyl-1, 3-oxazolidin-¬2-¬ones: ideal Michael acceptors to afford a virtually complete control of simple and face diastereoselectivity in addition reactions with glycine derivatives. Org. Lett. 2000. 2(6): 747–750.

doi.org/10.1021/ol990402f.

Soloshonok V.A., Cai C., Yamada T. et al. Michael addition reactions between chiral equivalents of a nucleophilic glycine and (S)-or (R)-3-[(E)-enoyl]-4-phenyl-1, 3-oxazolidin-2-ones as a general method for efficient preparation of β-substituted pyroglutamic acids. Case of topographically controlled stereoselectivity. J. Am. Chem. Soc. 2005. 127(43): 15296-15303.

doi.org/10.1021/ja0535561.

Guo T., Zhang L., Liu X. et al. Visible‐Light‐Promoted Redox‐Neutral Cyclopropanation Reactions of α‐Substituted Vinylphosphonates and Other Michael Acceptors with Chloromethyl Silicate as Methylene Transfer Reagent. Adv. Syn. Cat. 2018. 360(23): 4459–4463. doi.org/10.1002/adsc.201800761.

Phelan J.P., Lang S.B., Compton J.S. et al. Redox-neutral photocatalytic cyclopropanation via radical/polar crossover. J. Am. Chem. Soc. 2018. 140(25): 8037–8047.

doi.org/10.1021/jacs.8b05243.

Liu M., Ouyang X., Xuan C., Shu C. Advances in photoinduced radical–polar crossover cyclization (RPCC) of bifunctional alkenes. Org. Chem. Front. 2024. 11(3): 895–915.

doi.org/10.1039/D3QO01929B.

Teye‐Kau J.H., Ayodele M.J,. Pitre S.P. Vitamin B12‐Photocatalyzed Cyclopropanation of Electron‐Deficient Alkenes Using Dichloromethane as the Methylene Source. Angew. Chem. Int. Ed. 2024. 63(2): e202316064.

doi.org/10.1002/anie.202316064.

Marek W.K., Lee J.W., Seidel-Morgenstern A., Antos D. Separation of nonracemic mixtures of enantiomers by achiral simulated moving bed chromatography. Separation and Purification Technology. 2025. 361: 131497.

doi.org/10.1016/j.seppur.2025.131497.

Ueki H., Yasumoto M., Soloshonok V.A. Rational application of self-disproportionation of enantiomers via sublimation—a novel methodological dimension for enantiomeric purifications. Tetrahedron: Asymmetry. 2010. 21: 1396–1400.

doi.org/10.1016/j.tetasy.2010.04.040.

Han J., Wzorek A., Klika K.D., Soloshonok V.A. Recommended Tests for the Self-Disproportionation of Enantiomers (SDE) to Ensure Accurate Reporting of the Stereochemical Outcome of Enantioselective Reactions. Molecules 2021. 26: 2757.

doi.org/10.3390/molecules26092757.

Han J., Dembinski R., Soloshonok V.A., Klika K.D. A Call for a Change in Policy Regarding the Necessity for SDE Tests to Va¬lidate the Veracity of the Outcome of Enantioselective Syntheses, the Inherent Chiral State of Natural Products, and Other Cases Involving Enantioenriched Samples. Molecules. 2021. 26: 3994.

doi.org/10.3390/molecules26133994.

De Camp W.H. Chiral drugs: the FDA perspective on manufacturing and control. J. Phar. Biomed. Anal. 1993. 11(11-12): 1167–1172.

doi.org/10.1016/0731-7085(93)80100-F.

Daniels J.M., Nestmann E.R., Kerr A. Development of stereoisomers (chiral) drugs: A brief review of scientific and regulatory considerations. Drug Infor. J. 1997. 31: 639–646.

doi.org/10.1177/009286159703100303.

Ceramella J., Iacopetta D., Franchini A. et al. A look at the importance of chirality in drug activity: Some significative examples. App. Scien. 2022. 12(21): 10909.

doi.or

Завантаження

Дані завантаження ще не доступні.